The PCSK9 decade
Open Access
- 1 December 2012
- journal article
- review article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 53 (12), 2515-2524
- https://doi.org/10.1194/jlr.r026658
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- PCSK9 LNA Antisense Oligonucleotides Induce Sustained Reduction of LDL Cholesterol in Nonhuman PrimatesMolecular Therapy, 2012
- Growth Curves for Cardio-Metabolic Risk Factors in Children and AdolescentsThe Journal of Pediatrics, 2009
- Antibody-mediated disruption of the interaction between PCSK9 and the low-density lipoprotein receptorBiochemical Journal, 2009
- Versatility in ligand recognition by LDL receptor family proteins: advances and frontiersCurrent Opinion in Structural Biology, 2007
- Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activityBiochemical Journal, 2007
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseThe New England Journal of Medicine, 2006
- Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9Proceedings of the National Academy of Sciences of the United States of America, 2005
- Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotypeProceedings of the National Academy of Sciences of the United States of America, 2004
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiationProceedings of the National Academy of Sciences of the United States of America, 2003